Viatris wins summary judgment in new york securities class action

All pending claims have been dismissed pittsburgh , march 31, 2023 /prnewswire/ -- viatris inc. (nasdaq: vtrs) announced that the u.s. district court for the southern district of new york has dismissed all claims against the company in their entirety and granted its motion for summary judgment in the securities class action related to the company's marketing, pricing, and classification of epipen, as well as alleged conduct concerning generic drug price fixing and market allocation. the decision addressed all pending claims against all defendants.
VTRS Ratings Summary
VTRS Quant Ranking